Advanced search
Publication Cover
Future Oncology Volume 12, 2016 - Issue 18
Submit an article Journal homepage
2,880
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Erlotinib for Japanese Patients with Activating EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Combined Analyses from Two Phase II Studies

Shinji Atagi1 Kinki-chuo Chest Medical Center, Osaka, JapanCorrespondence[email protected]
,
Koichi Goto2 National Cancer Center Hospital East, Chiba, Japan
,
Takashi Seto3 National Kyushu Cancer Center, Fukuoka, Japan
,
Nobuyuki Yamamoto4 Wakayama Medical University, Wakayama, Japan
,
Tomohide Tamura5 St Luke’s International Hospital, Tokyo, Japan
,
Kosei Tajima6 Chugai Pharmaceutical Co. Ltd, Tokyo, Japan
&
Naohito Inagaki6 Chugai Pharmaceutical Co. Ltd, Tokyo, Japan
 show all
Pages 2117-2126 | Received 31 Mar 2016, Accepted 11 May 2016, Published online: 07 Jun 2016

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.